Donna Felsenstein: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "first2=Jonathan Z.|author-link2=|last3=Felsenstein|first3=Donna|author-link3=Donna Felsenstein|last4=Kotton|first4=Camille N.|" to "first2=Jonathan Z.|author-link2=|last3=Felsenstein|first3=Donna|author-link3=Donna Felsenstein|las...) |
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
||
Line 26: | Line 26: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="KlimasNG, 2015">{{Citation | <ref name="KlimasNG, 2015">{{Citation |last1 = Klimas |first 1 |authorlink1 = Nancy Klimas |last2 = Ironson |first 2 |authorlink2 = |last3 = Carter |first 3 |authorlink3 = |last4 = Balbin |first 4 |authorlink4 = Elizabeth Balbin |last5 = Bateman |first 5 |authorlink5 = Lucinda Bateman |last6 = Felsenstein |first 6 |authorlink6 = Donna Felsenstein |last7 = Levine |first 7 |authorlink7 = Susan Levine |last8 = Peterson |first 8 |authorlink8 = Daniel Peterson |last9 = Chiu |first 9 |authorlink9 = |last10 = Allen |first 10 |authorlink10 = |last11 = Cunningham |first 11 |authorlink11 = |last12 = Gottschalk |first 12 |authorlink12 = Gunnar Gottschalk |last13 = Fletcher |first 13 |authorlink13 = Mary Ann Fletcher |last14 = Hornig |first 14 |authorlink14 = Mady Hornig |last15 = Canning |first 15 |authorlink15 = |last16 = Komaroff |first 16 |authorlink16 = Anthony Komaroff | ||
| last1 = Klimas | |||
| last2 = Ironson | |||
| last3 = Carter | |||
| last4 = Balbin | |||
| last5 = Bateman | |||
| last6 = Felsenstein | |||
| last7 = Levine | |||
| last8 = Peterson | |||
| last9 = Chiu | |||
| last10 = Allen | |||
| last11 = Cunningham | |||
| last12 = Gottschalk | |||
| last13 = Fletcher | |||
| last14 = Hornig | |||
| last15 = Canning | |||
| last16 = Komaroff | |||
| title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2| page = 75-96 |
Revision as of 04:45, May 11, 2022
Donna Felsenstein, M.D., is an Internal Medicine and Infectious Disease physician who practices at the Massachusetts General Hospital, Boston, MA, US[1] and is a Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH).[2] She serves as a member of the scientific team with the Open Medicine Foundation.[2] Since 1979, she has been diagnosing and caring for patients with ME/CFS.[2] Her listed specialities include Lyme disease, Infectious diseases, and Herpes simplex virus.[1]
Notable studies[edit | edit source]
- 2010, Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions[3] - (Full text)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[4] - (Full text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[5] - (Abstract)
Clinic location[edit | edit source]
55 Fruit St, Boston, MA 02114
Phone: (617) 726-3812
Talks and interviews[edit | edit source]
- 8 June 2019, Clinician Panel Discussion on ME/CFS, given at the Inaugural Harvard ME/CFS Collaboration Symposium sponsored by Open Medicine Foundation
- 17 November 2020, https://www.youtube.com/watch?v=quUTD4v-9lc&t=9s&ab_channel=MassMECFS%26FM, Massachusetts ME/CFS & FM Association http://www.massmecfs.org/ and Open Medicine Foundation Fall 2020 Event on Zoom
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 "Donna Felsenstein, MD - Infectious Diseases - Massachusetts General Hospital, Boston, MA". www.massgeneral.org. Retrieved September 3, 2019.
- ↑ 2.0 2.1 2.2 "ME/CFS Collaborative Research Center at Harvard, funded by OMF". Open Medicine Foundation. Retrieved September 3, 2019.
- ↑ Henrich, Timothy J.; Li, Jonathan Z.; Felsenstein, Donna; Kotton, Camille N.; Plenge, Robert M.; Pereyra, Florencia; Marty, Francisco M.; Lin, Nina H.; Grazioso, Paul (November 15, 2010). "Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions". The Journal of Infectious Diseases. 202 (10): 1478–1481. doi:10.1086/657168. ISSN 0022-1899. PMC 2957553. PMID 20936980.
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ 1first 2 first 1 first 3 first 2, "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome"